Literature DB >> 3403716

New amber mutation in a beta-thalassemic gene with nonmeasurable levels of mutant messenger RNA in vivo.

G F Atweh1, H E Brickner, X X Zhu, H H Kazazian, B G Forget.   

Abstract

We have identified a beta-thalassemia gene that carries a novel nonsense mutation in a Chinese patient. This mutation, a G to T substitution at the first position of codon 43, changes the glutamic acid coding triplet (GAG) to a terminator codon (TAG). Based on oligonucleotide hybridization studies of 78 Chinese and Southeast Asian beta-thalassemia chromosomes, we estimate that this mutation accounts for a small minority of the beta-thalassemia mutations in that population. Study of the expression of this cloned gene in a transient expression system demonstrated a 65% decrease in levels of normally spliced mutant beta-globin mRNA. However, the study of reticulocyte RNA isolated from an individual heterozygous for this mutation demonstrated a total absence of this mutant mRNA in vivo. The basis for this big discrepancy between the level of accumulated mRNA in vivo and in vitro is probably the result of differences in the stabilities of the mutant mRNA in erythroid cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3403716      PMCID: PMC303548          DOI: 10.1172/JCI113632

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase.

Authors:  F Sanger; A R Coulson
Journal:  J Mol Biol       Date:  1975-05-25       Impact factor: 5.469

2.  Biochemical method for mapping mutational alterations in DNA with S1 nuclease: the location of deletions and temperature-sensitive mutations in simian virus 40.

Authors:  T E Shenk; C Rhodes; P W Rigby; P Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

3.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

4.  Mapping of RNA by a modification of the Berk-Sharp procedure: the 5' termini of 15 S beta-globin mRNA precursor and mature 10 s beta-globin mRNA have identical map coordinates.

Authors:  R F Weaver; C Weissmann
Journal:  Nucleic Acids Res       Date:  1979-11-10       Impact factor: 16.971

5.  Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.

Authors:  J Favaloro; R Treisman; R Kamen
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Structure and expression of a cloned beta o thalassaemic globin gene.

Authors:  N Moschonas; E de Boer; F G Grosveld; H H Dahl; S Wright; C K Shewmaker; R A Flavell
Journal:  Nucleic Acids Res       Date:  1981-09-11       Impact factor: 16.971

7.  The nucleotide sequence of the human beta-globin gene.

Authors:  R M Lawn; A Efstratiadis; C O'Connell; T Maniatis
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

8.  Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster.

Authors:  S H Orkin; H H Kazazian; S E Antonarakis; S C Goff; C D Boehm; J P Sexton; P G Waber; P J Giardina
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

9.  Suppression of the nonsense mutation in homozygous beta 0 thalassaemia.

Authors:  J C Chang; G F Temple; R F Trecartin; Y W Kan
Journal:  Nature       Date:  1979-10-18       Impact factor: 49.962

10.  beta 0 thalassemia, a nonsense mutation in man.

Authors:  J C Chang; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

View more
  21 in total

1.  Anti-Müllerian hormone Bruxelles: a nonsense mutation associated with the persistent Müllerian duct syndrome.

Authors:  B Knebelmann; L Boussin; D Guerrier; L Legeai; A Kahn; N Josso; J Y Picard
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

2.  Molecular definition of bovine argininosuccinate synthetase deficiency.

Authors:  J A Dennis; P J Healy; A L Beaudet; W E O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 3.  Molecular basis of androgen resistance.

Authors:  M Marcelli; W D Tilley; S Zoppi; J E Griffin; J D Wilson; M J McPhaul
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

4.  Abnormal messenger ribonucleic acid (mRNA) transcribed from a mutant insulin receptor gene in a patient with type A insulin resistance.

Authors:  F Shimada; Y Suzuki; M Taira; N Hashimoto; O Nozaki; H Makino; S Yoshida
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

5.  A single base deletion in the Tfm androgen receptor gene creates a short-lived messenger RNA that directs internal translation initiation.

Authors:  M L Gaspar; T Meo; P Bourgarel; J L Guenet; M Tosi
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

6.  Mutational analysis of a patient with mucopolysaccharidosis type VII, and identification of pseudogenes.

Authors:  J M Shipley; M Klinkenberg; B M Wu; D R Bachinsky; J H Grubb; W S Sly
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

7.  Nonsense codons in human beta-globin mRNA result in the production of mRNA degradation products.

Authors:  S K Lim; C D Sigmund; K W Gross; L E Maquat
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

8.  Five mutant alleles of the insulin receptor gene in patients with genetic forms of insulin resistance.

Authors:  T Kadowaki; H Kadowaki; M M Rechler; M Serrano-Rios; J Roth; P Gorden; S I Taylor
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

Review 9.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

10.  Nonsense mutations affect C1 inhibitor messenger RNA levels in patients with type I hereditary angioneurotic edema.

Authors:  D Frangi; M Cicardi; A Sica; F Colotta; A Agostoni; A E Davis
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.